triage

Analysis of the Intellectual Property behind the Dell v. Hewlett-Packard Bidding War for 3PAR, Inc.

This week’s Patently Obvious report focuses on the patent holdings of 3PAR, Inc. On September 2, 2010, Hewlett-Packard weathered a bidding war with Dell Computer for 3PAR, offering $2.3 billion, or $24 a share, for the company -- almost $1.15 billion more than Dell's original offer for the company.

In the frenzy of attempting to place the winning bid, neither HP nor Dell fully considered the potential liabilities associated with owning 3PAR's intellectual property. For $2 billion, HP may have purchased the right to settle over $3 billion of new patent lawsuits.

ShareThis

Analysis of the Intellectual Property behind Sanofi-Aventis' proposed acquisition of Genzyme

This week’s Patently Obvious report focuses on the patent holdings of Genzyme Corporation (NASDAQ:GENZ). On August 30th French drug maker Sanofi-Aventis SA (NYSE:SNY) went public with their offer to acquire Genzyme. The offer, at $69 dollars a share for a $18.5 billion total price, was rejected by Genzyme.

Sanofi-Aventis will have to fully consider the potential liabilities associated with owning Genzyme's intellectual property before increasing their bid. Genzyme has faced a slew of troubles recently and the cracks run deeper than the surface.

ShareThis

Analysis of the Intellectual Property of Network-1 Security Solutions, Inc.

On February 7, 2008 Network-1, a non-practicing entity, brought patent infringement charges against Cisco Systems, Inc. and seven other companies over U.S. Patent No. 6,218,930. On July 19, 2010, Network-1 announced that they had reached a settlement with Cisco, among others. Under the terms of the settlement, Cisco must make an upfront payment to Network-1 as well as royalty payments throughout the term of the '930 patent.

This report focuses on patents of interest which predate and are concurrent to Network-1's '930 patent, including public-domain alternatives.

ShareThis
Syndicate content